Nintedanib 150 mg Capsules – Product Overview & Pharmaceutical Information
Nintedanib 150 mg Capsules – Overview
Nintedanib 150 mg Capsules contain nintedanib, a prescription medicine belonging to the class of tyrosine kinase inhibitors. It is used under medical supervision for certain chronic lung conditions, including idiopathic pulmonary fibrosis (IPF) and some other forms of progressive fibrosing interstitial lung disease. It is also used in combination with docetaxel for certain patients with advanced non-small-cell lung cancer, depending on applicable treatment guidelines and approvals.
Nintedanib works by inhibiting several growth-factor receptors involved in processes associated with abnormal tissue and blood-vessel growth. Treatment should be initiated and monitored by an appropriately qualified healthcare professional.
Product Information
Product Name: Nintedanib 150 mg Capsules
Active Ingredient: Nintedanib
Strength: 150 mg
Dosage Form: Oral capsule
Therapeutic Area: Respiratory medicine / oncology
Prescription Status: Prescription medicine
Administration: Taken orally according to the prescribing healthcare professional's instructions
Important Medical Information
Nintedanib can cause side effects and may require monitoring during treatment. Commonly reported adverse effects include gastrointestinal symptoms such as diarrhea, nausea, vomiting, abdominal discomfort, and reduced appetite. Liver-function monitoring may also be required.
Patients should use nintedanib only under the direction of a qualified healthcare professional. The appropriate dose, treatment duration, interactions, precautions, and suitability depend on the individual patient's medical circumstances.
Global Pharmaceutical Information
Nintedanib is used in healthcare systems in various international markets. Availability, prescribing requirements, approved indications, and product registration can differ between countries.
Healthcare and pharmaceutical organizations operating in international markets may include major cities such as:
United States: New York, Los Angeles, Chicago, Houston, Boston
United Kingdom: London, Birmingham, Manchester, Glasgow
Canada: Toronto, Vancouver, Montreal, Calgary
Australia: Sydney, Melbourne, Brisbane, Perth
UAE: Dubai, Abu Dhabi, Sharjah
Singapore: Singapore
South Africa: Johannesburg, Cape Town, Durban
Germany: Berlin, Munich, Frankfurt
France: Paris, Lyon, Marseille
India: Mumbai, Delhi, Bengaluru, Hyderabad
Actual availability and lawful supply depend on local pharmaceutical regulations, prescription requirements, import rules, and product authorization.
Contact More details @ radhakrishnamedmart@gmail.com
Radha Krishna Medmart provides information and pharmaceutical supply-chain services for international healthcare markets. Businesses and healthcare professionals should verify applicable regulatory requirements before handling or distributing prescription medicines internationally.
Official websites:
https://www.visionpharmaexport.com/
https://www.medicineexports.com/
https://www.globalsteroidpharma.com
https://www.edmedsexpoter.com/
Frequently Asked Questions
Q1. What is Nintedanib 150 mg used for?
Nintedanib is a prescription medicine used for certain fibrosing lung diseases, including idiopathic pulmonary fibrosis, and for specific oncology indications according to applicable medical guidance.
Q2. What is the active ingredient in Nintedanib 150 mg Capsules?
The active ingredient is nintedanib, a tyrosine kinase inhibitor.
Q3. Is Nintedanib 150 mg a prescription medicine?
Yes. Nintedanib should be used under the supervision of an appropriately qualified healthcare professional.
Q4. Does nintedanib require medical monitoring?
Yes. Depending on the patient and treatment circumstances, healthcare professionals may monitor liver function and other aspects of treatment.
Q5. Are the approved uses of nintedanib identical in every country?
No. Approved indications, product registrations, prescribing requirements, and availability can vary between countries.
Q6. How can I contact Radha Krishna Medmart?
Email: visionpharmaglobal@gmail.com
Contact No: +91 9326646654
Nintedanib 150 mg Capsules, nintedanib pharmaceutical information, nintedanib 150 mg overview, nintedanib prescription medicine, antifibrotic therapy, idiopathic pulmonary fibrosis treatment, interstitial lung disease treatment, tyrosine kinase inhibitor, respiratory medicine, pharmaceutical information, global pharmaceutical supplier.
